Primaquine disposition in the isolated perfused rat liver: Effect of mefloquine induced bile flow reduction
β Scribed by Michael D. Coleman; Lawrence Fleckenstein; Melvin H. Heiffer
- Publisher
- John Wiley and Sons
- Year
- 1989
- Tongue
- English
- Weight
- 524 KB
- Volume
- 10
- Category
- Article
- ISSN
- 0142-2782
No coin nor oath required. For personal study only.
β¦ Synopsis
The disposition of primaquine (0.75 mg, 5 pC1) has been investigated in the isolated perfused rat liver (IPRL) preparation alone and concurrently with mefloquine. In both groups, primaquine concentrations declined exponentially. There were no significant differences between the respective groups in the half-lives (2-5 f 1-5, 2.2 f 1.1 h), AUCs (0.43 f 0.14, 0.372 f 0.096wghml-'), clearances (19.0 f 5.4, 21.1 f 4.2 rnl h-I), and apparent volume of distribution (78.9 f 28-1, 76.2 f 31.7ml). In the presence of mefloquine, total bile production was significantly reduced (1244.5 f 317.1 111) compared with primaquine alone (1621.5 f 174.2 111). Hence, although significantly less radioactivity (['HI) was eliminated in bile in the presence of mefloquine (30.0 ?r 7.9 per cent versus 39.9 2 3.6 per cent) there was no significant difference between the groups in ['H]/pl bile eliminated. Significantly more ['HI was recovered from the livers of the mefloquine/ primaquine group. This was underlined by the significantly greater proportions of ['HI recovered from the 10000 g pellet, 10000 g supernatant and 105000 g supernatant in the presence of mefloquine compared with primaquine alone. Hence, it appears mefloquine had little or no direct action or primaquine metabolism, but significantly reduced bile production.
π SIMILAR VOLUMES
NO synthase and have the capacity to produce large amounts Nitric oxide (NO) modulates several metabolic funcof NO in response to lipopolysaccharides and inflammatory tions in hepatocytes, but the role of NO in bile secretion cytokines. [3][4][5][6] NO donors, such as sodium nitroprusside (SNP) has
The hepatobiliary disposition of rhodamine 123 (RH-123) and its glucuronidated (RH-Glu) and deacylated (RH-110) metabolites were studied in an isolated perfused rat liver (IPRL) model in the presence and absence of P-glycoprotein (P-gp) and Mrp2 inhibitors. A single dose (180 mg) of RH-123 was added